Corporate & B2B
Transforming the future of cancer diagnostics
DXCOVER
The brief
Following a round of investor funding and a brand name change (formerly Clinspec Dx), Dxcover asked us to create a new brand identity and website platform that would position them as pioneering disruptors in the cancer diagnostics market to support their global expansion plans.
The work
Dxcover wanted to be seen as disruptors to the cancer diagnostics market. Based on their ground-breaking approach to diagnosis that uses machine learning and a liquid biopsy test process that’s simpler and faster than anything else on the market, we could position Dxcover as the people leading the way.
